Ignite Creation Date:
2024-05-05 @ 11:36 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01379534
Status:
COMPLETED
Last Update Posted:
2015-05-20
First Post:
2011-06-06
Brief Title:
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced andor Metastatic Endometrial Cancer
Sponsor:
Organization:
Novartis